TOWER Cold Chain Solutions, the Theale-based provider of reusable thermal packaging solutions to the pharmaceutical industry, is poised to develop its market with support from the Thames Valley Berkshire Growth Fund. TOWER’s containers, offering a powerful, passive and environmentally-sound way of transporting valuable pharmaceuticals, are in use with major pharmaceutical companies across the world.
The Temperature Controlled Logistics Forum is an industry-leading event, where the life-sciences temperature-controlled logistics industry meets to discuss the future of the life-sciences supply chain, innovations and progress.
The European Union published updated regulatory guidance for Good Distribution Practice in March 2013, of which the biggest change was to require temperature data and auditing of ‘ambient’ or ‘controlled-room-temperature’ (CRT) product shipments. This came as an unprecedented change to the industry, with these products previously being assumed safe without the need for monitoring.
TOWER Cold Chain Solutions, suppliers of the KryoTrans® range of passive thermal containers, has extended its global reach by opening its corporate office in New York. TOWER already supports three US hub locations in New York, Los Angeles and San Francisco with the Manhattan office adding further administrative support for its US customer base.
The total cost of shipping temperature-sensitive pharmaceutical goods is routinely calculated as packaging plus freight, but this is a misconception with many other related and often overlooked factors within the overall supply-chain contributing to the true total cost.